The injectable, Lenacapavir, is expected to play a key role in efforts to eliminate HIV, following UNAIDS’ call for countries to end the epidemic amid funding challenges.

Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...

Georgia nonprofit leaders said the Trump administration’s federal grant cuts are already affecting their operations – and ...

The city of San Francisco reported an increase of 4.3% in the number of new cases of HIV diagnosed last year. That’s a rise ...

Dr David Adetula is the Founder of Healthialogue and Convener of the Healthialogue Panel Session and Discussion Forum and Christian Okike is the President of the Medical Research and Humanitarian ...

Two partnerships will provide millions of people access to what is widely described as the most effective HIV prevention drug ...

Attorney General James Uthmeier announced on Wednesday that a $3 million settlement agreement with Gilead Sciences, Inc.

Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...

Stony Brook University Hospital has been rated the top hospital for pediatric care in New York State by personal finance ...

Learn about Christopher Green's journey with HIV, the stigma surrounding the disease, and the systemic inequities that drive ...

Purpose: To determine the prevalence and risk factors for the occurrence of esophageal mycosis in HIV negative subjects.